The total return over the past 12 months is +30.67% vs. +18.21% for the S&P 500. So far it's up +7.83% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +30.67% | (7.77%) | (15.07%) | +8.45% | +7.59% | +8.32% |
| Total Return CAGR | +30.67% | (7.77%) | (15.07%) | +8.45% | +7.59% | +8.32% |
| Revenue CAGR | +1.92% | (2.32%) | +0.29% | +2.53% | +1.88% | +3.96% |
| Net Income CAGR | N/A | N/A | (47.16%) | +4.61% | (0.56%) | +3.85% |
| EPS CAGR | N/A | N/A | (26.27%) | +22.24% | +9.97% | +11.55% |
| Free Cash Flow CAGR | +7.56% | +41.79% | (7.57%) | +24.78% | +6.88% | +25.62% |
| Operating Cash Flow CAGR | (0.95%) | +26.38% | (4.01%) | +13.08% | +5.66% | +13.39% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bio-Rad Laboratories, Inc. (BIO)
| Year | Start Value | End Value | BIO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 2080.62 | 2243.57 | +7.83% | +9.34% | (1.51%) |
| 2025 | 2255.86 | 2080.62 | (7.77%) | +17.72% | (25.49%) |
| 2024 | 2217.27 | 2255.86 | +1.74% | +24.89% | (23.15%) |
| 2023 | 2887.48 | 2217.27 | (23.21%) | +26.19% | (49.40%) |
| 2022 | 5188.46 | 2887.48 | (44.35%) | (18.17%) | (26.18%) |
| 2021 | 4003.02 | 5188.46 | +29.61% | +28.74% | +0.87% |
| 2020 | 2540.98 | 4003.02 | +57.54% | +18.37% | +39.17% |
| 2019 | 1594.64 | 2540.98 | +59.34% | +31.22% | +28.12% |
| 2018 | 1638.94 | 1594.64 | (2.70%) | (4.56%) | +1.86% |
| 2017 | 1251.71 | 1638.94 | +30.94% | +21.70% | +9.24% |
